Product Features
Product Name:
Regonix
Generic Name:
Regorafenib
Manufacturer:
Beacon Pharmaceuticals
Formulation:
Tablet
Pack Size:
28 Tablets
Strengths:
40 mg
Price:
$ 250

  Introduction

Regorafenib is an oral multi-kinase inhibitor developed by Bayer which targets angiogenic, stromal and oncogenic receptor tyrosine kinase (RTK). Regorafenib shows anti-angiogenic activity due to its dual targeted VEGFR2-TIE2 tyrosine kinase inhibition. Since 2009 it was studied as a potential treatment option in multiple tumor types. By 2015 it had 2 US approvals for advanced cancers.

  Indication

Regorafenib is used to treat colorectal cancer and liver cancer. It is also used to treat a rare type of tumor that can affect the esophagus, stomach, or intestines.

Regorafenib is usually given after other cancer medications have been tried without success.

  Usage & Dosage

Regorafenib is usually taken daily for 3 weeks followed by 1 week off the medicine.

Your doctor will determine how many times you should repeat this treatment cycle.